Insider Selling: Arteris (NASDAQ:AIP) VP Sells $120,160.00 in Stock

Arteris, Inc. (NASDAQ:AIP) VP Paul Alpern sold 4,000 shares of the firm’s stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $30.04, for a total value of $120,160.00. Following the completion of the sale, the vice president directly owned 70,733 shares of the company’s stock, valued at approximately $2,124,819.32. This trade represents a 5.35% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Arteris Stock Performance

NASDAQ:AIP opened at $29.78 on Friday. The firm’s fifty day simple moving average is $35.94 and its 200-day simple moving average is $26.19. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.17. The stock has a market cap of $1.37 billion, a PE ratio of -34.23 and a beta of 1.96. Arteris, Inc. has a fifty-two week low of $8.42 and a fifty-two week high of $50.26.

Arteris (NASDAQ:AIP) last released its quarterly earnings data on Thursday, August 6th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.06). The company had revenue of $24.13 million during the quarter, compared to analysts’ expectations of $23.48 million. Analysts expect that Arteris, Inc. will post -0.58 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Arteris

A number of institutional investors have recently made changes to their positions in AIP. Raymond James Financial Inc. acquired a new stake in shares of Arteris during the second quarter valued at $32,000. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in Arteris in the 2nd quarter valued at about $53,000. Versant Capital Management Inc raised its stake in Arteris by 33.7% in the 2nd quarter. Versant Capital Management Inc now owns 1,150 shares of the company’s stock valued at $56,000 after purchasing an additional 290 shares during the last quarter. BNP Paribas Financial Markets lifted its holdings in Arteris by 75.0% in the 3rd quarter. BNP Paribas Financial Markets now owns 6,053 shares of the company’s stock valued at $61,000 after purchasing an additional 2,595 shares in the last quarter. Finally, Royal Bank of Canada lifted its holdings in Arteris by 366.7% in the 1st quarter. Royal Bank of Canada now owns 4,023 shares of the company’s stock valued at $66,000 after purchasing an additional 3,161 shares in the last quarter. 64.36% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently commented on AIP shares. Weiss Ratings lowered shares of Arteris from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 13th. Northland Securities set a $38.00 target price on shares of Arteris in a report on Wednesday, May 13th. Rosenblatt Securities restated a “buy” rating and set a $38.00 target price on shares of Arteris in a research report on Friday. TD Cowen upped their price target on shares of Arteris from $22.00 to $40.00 and gave the company a “buy” rating in a report on Wednesday, May 13th. Finally, Roth Capital began coverage on shares of Arteris in a research report on Tuesday. They issued a “buy” rating and a $40.00 price target on the stock. Five investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, Arteris currently has a consensus rating of “Moderate Buy” and a consensus price target of $41.00.

Trending Headlines about Arteris

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Jefferies upgraded Arteris from Hold to Buy and assigned a $50 price target, indicating substantial potential upside. Jefferies upgrade
• Positive Sentiment: Rosenblatt Securities reaffirmed its Buy rating and raised or maintained a $38 price target, while Roth Capital also initiated coverage with a Buy rating and a $40 target. The endorsements strengthen the bullish analyst backdrop for AIP. Rosenblatt rating Roth Capital rating
• Positive Sentiment: Arteris projected third-quarter revenue of $24 million to $25 million and updated full-year 2026 revenue guidance to $95 million to $98 million. Both ranges exceed consensus estimates of approximately $23.5 million and $94.2 million, respectively. Arteris results and guidance
• Neutral Sentiment: The company appointed Saurabh Sinha as chief financial officer and chief accounting officer, effective September 8, 2026. The leadership change may improve financial oversight, but investors may initially monitor the transition. CFO appointment
• Negative Sentiment: Second-quarter adjusted results showed a loss of $0.10 per share, worse than the expected loss of roughly $0.04-$0.05. Revenue of $24.13 million exceeded estimates, but the larger-than-expected loss likely drove selling pressure. Arteris second-quarter results
• Negative Sentiment: Recent filings disclosed sales by CEO K. Charles Janac, director Saiyed Atiq Raza, major shareholder Bayview Legacy and Vice President Paul Alpern. The concentration of insider selling may weigh on sentiment, although insiders retain significant positions.

Arteris Company Profile

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.